ascopubs.org

Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study.

KEYNOTE-059 cohort 2: Safety and efficacy of pembrolizumab (pembro) plus 5-fluorouracil (5-FU) and cisplatin for first-line (1L) treatment of advanced gastric cancer. Nivolumab ± ipilimumab in pts ...
ascopubs.org

Sorafenib (SOR) safety profile in more than 4,600 patients (pts) with renal cell carcinoma (RCC): Assessment at 3-month (mo) intervals using an integrated database of eight ...

Sunitinib in papillary renal cell carcinoma (pRCC): Results from a single-arm phase II study. Background: With >5 yrs of clinical experience with SOR, a well-defined efficacy and safety profile has ...